PFE

Pfizer, Inc.

27.59 USD
-0.08 (-0.29%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pfizer, Inc. stock is down -2.95% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46% of the previous 49 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 4 CALLs, 6 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Feb 17:01 17 Jan, 2025 25.00 CALL 65 32349
22 Feb 17:02 19 Apr, 2024 27.50 PUT 5000 24926
22 Feb 17:09 20 Jun, 2025 28.00 PUT 1000 7325
22 Feb 17:29 19 Dec, 2025 37.50 CALL 236 2671
22 Feb 17:54 17 Jan, 2025 27.50 CALL 100 10021
22 Feb 17:56 17 Jan, 2025 27.50 CALL 301 10021
22 Feb 18:05 19 Dec, 2025 22.50 PUT 3400 5589
22 Feb 19:50 20 Jun, 2025 20.00 PUT 1500 1426
22 Feb 19:54 20 Jun, 2025 20.00 PUT 1700 1426
22 Feb 20:39 20 Jun, 2025 25.00 PUT 144 12532

About Pfizer, Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health. The company also provides biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Cibinqo brands.